全文获取类型
收费全文 | 1329385篇 |
免费 | 105197篇 |
国内免费 | 6136篇 |
专业分类
耳鼻咽喉 | 19018篇 |
儿科学 | 44829篇 |
妇产科学 | 35551篇 |
基础医学 | 188163篇 |
口腔科学 | 34724篇 |
临床医学 | 118198篇 |
内科学 | 264596篇 |
皮肤病学 | 28647篇 |
神经病学 | 102520篇 |
特种医学 | 53047篇 |
外国民族医学 | 701篇 |
外科学 | 201708篇 |
综合类 | 37613篇 |
现状与发展 | 20篇 |
一般理论 | 390篇 |
预防医学 | 99571篇 |
眼科学 | 29438篇 |
药学 | 100830篇 |
67篇 | |
中国医学 | 5862篇 |
肿瘤学 | 75225篇 |
出版年
2021年 | 10690篇 |
2019年 | 10984篇 |
2018年 | 15150篇 |
2017年 | 11759篇 |
2016年 | 12542篇 |
2015年 | 15149篇 |
2014年 | 20519篇 |
2013年 | 29110篇 |
2012年 | 40191篇 |
2011年 | 42705篇 |
2010年 | 26029篇 |
2009年 | 24434篇 |
2008年 | 39751篇 |
2007年 | 42344篇 |
2006年 | 42588篇 |
2005年 | 41426篇 |
2004年 | 39795篇 |
2003年 | 38506篇 |
2002年 | 37458篇 |
2001年 | 65331篇 |
2000年 | 67748篇 |
1999年 | 57704篇 |
1998年 | 16018篇 |
1997年 | 14532篇 |
1996年 | 14007篇 |
1995年 | 14039篇 |
1994年 | 13264篇 |
1993年 | 12048篇 |
1992年 | 44838篇 |
1991年 | 43768篇 |
1990年 | 42472篇 |
1989年 | 40311篇 |
1988年 | 37050篇 |
1987年 | 36396篇 |
1986年 | 33714篇 |
1985年 | 32374篇 |
1984年 | 24177篇 |
1983年 | 20250篇 |
1982年 | 11704篇 |
1981年 | 10664篇 |
1979年 | 21321篇 |
1978年 | 14785篇 |
1977年 | 12490篇 |
1976年 | 11668篇 |
1975年 | 12600篇 |
1974年 | 14643篇 |
1973年 | 14101篇 |
1972年 | 12938篇 |
1971年 | 11714篇 |
1970年 | 11039篇 |
排序方式: 共有10000条查询结果,搜索用时 671 毫秒
101.
目的 探讨构建的可切除肺癌预后预测模型在患者生存及预后预测中的价值。方法 选择山西省肿瘤医院2007年1月至2018年9月原发性肺癌患者2 267例,患者均行一次肺癌手术治疗,无第二原发肿瘤。选取性别、年龄、职业、肿瘤部位、病理类型、手术路径、手术方式、肿瘤分期、治疗方案为预后影响因素。采用Cox比例风险模型构建预后指数(PI)方程,计算每例患者的PI值。根据PI值的不同范围,划分低、中、高危预后组,对各组生存情况进行评估。结果 性别(RR=0.684,P=0.001)、年龄(RR=0.591,P<0.01)、职业(RR=1.439,P=0.001)、病理类型(RR=3.694,P<0.01)、手术路径(RR=0.734,P=0.001)、肿瘤分期(RR=0.352,P=0.007)为可切除肺癌患者预后独立影响因素。其中,女性、≤65岁、胸腔镜手术、肿瘤分期Ⅰ期为预后保护因素,其预后不良风险分别降低31.6%、40.9%、26.6%、64.8%;农民、腺鳞癌为预后危险因素,其预后不良风险分别增加43.9%、269.4%。PI方程为:∑βixi=-0.380 X1-0.526 X2+0.364 X31+1.307 X55-0.309 X6-1.045 X81(X1代表性别,X2代表年龄,X31代表职业为农民,X55代表病理类型为腺鳞癌,X6代表手术路径,X81代表肿瘤分期Ⅰ期)。PI<-1为低危组,PI≥-1且≤-0.5为中危组,PI>-0.5为高危组。1、3、5年生存率低危组分别为96.8%、87.0%、77.9%,中危组分别为91.8%、82.2%、61.7%,高危组分别为86.5%、61.7%、50.3%,各组间生存率差异具有统计学意义(P<0.05)。结论 可切除肺癌预后预测模型能够预测可切除肺癌患者的预后风险及相应生存率,帮助临床医师评估预后及制订后续治疗方案。 相似文献
102.
103.
104.
105.
106.
107.
108.
F. Giovanardi F. Nudo Q. Lai M. Garofalo A. Consolo E. Choppin De Janvry G.A. Arroyo Murillo P. Ursi D. Stabile F. Melandro P.B. Berloco R. Pretagostini L. Poli 《Transplantation proceedings》2019,51(1):128-131
Background
Arterial vascular anomalies in patients undergoing kidney transplantation (KT) are correlated with a higher incidence of early surgical complications, potentially causing graft loss. Arterial reconstruction allows patients to overcome these surgical challenges, thus minimizing the risk of poor outcomes. The aim of the present study is to retrospectively investigate the safety and effectiveness of the multiple arterial reconstruction technique with a Teflon patch in case of an unavailable aortic patch: to do so, surgical complications, graft function, and patient survival were evaluated.Methods
During the period January 2009 to August 2016, 202 adult deceased-donor KTs were performed at our center. Group A (n = 27; reconstruction of multiple arteries) and Group B (n = 175; control group) were compared.Results
No differences were observed between the 2 groups in terms of early postoperative course, with no vascular complication observed in Group A. No vascular patch infections were reported, nor longer cold ischemia time rates. Similarly, long-term survival rates were similar between the 2 groups.Conclusions
The Teflon-patch arterial reconstruction technique appears to be safe and effective, with an acceptable balance of benefits and potential risks of using a prosthetic material. Studies based on larger series are needed to further validate this approach. 相似文献109.
Paul J. Devlin Brian W. McCrindle James K. Kirklin Eugene H. Blackstone William M. DeCampli Christopher A. Caldarone Ali Dodge-Khatami Pirooz Eghtesady James M. Meza Peter J. Gruber Kristine J. Guleserian Bahaaladin Alsoufi Linda M. Lambert James E. OBrien Erle H. Austin Jeffrey P. Jacobs Tara Karamlou 《The Journal of thoracic and cardiovascular surgery》2019,157(2):684-695.e8
Objective
Arch obstruction after the Norwood procedure is common and contributes to mortality. We determined the prevalence, associated factors, and practice variability of arch reintervention and assessed whether arch reintervention is associated with mortality.Methods
From 2005 to 2017, 593 neonates in the Congenital Heart Surgeons' Society Critical Left Heart Obstruction cohort underwent a Norwood procedure. Median follow-up was 3.7 years. Multivariable parametric models, including a modulated renewal analysis, were performed.Results
Of the 593 neonates, 146 (25%) underwent 218 reinterventions for arch obstruction after the Norwood procedure: catheter-based (n = 168) or surgical (n = 50) at a median age of 4.3 months (quartile 1-quartile 3, 2.6-5.7). Interdigitation of the distal aortic anastomosis was protective against arch reintervention. Development of ≥ moderate tricuspid valve regurgitation and right ventricular dysfunction at any point was associated with arch reintervention. Nonsignificant variables for arch reintervention included shunt type and preoperative aortic measurements. Surgical arch reintervention was protective against arch reintervention, but transcatheter reintervention was associated with increased reintervention. Arch reintervention was not associated with increased mortality. There was wide institutional variation in incidence of arch reintervention (range, 0-40 reinterventions per 100 years patient follow-up) and in preintervention gradient (range, 0-64 mm Hg).Conclusions
Interdigitation of the distal aortic anastomosis during the Norwood procedure decreased the risk of arch reintervention. Surgical arch reintervention is more definitive than transcatheter. Arch reintervention after the Norwood procedure is not associated with increased mortality. Serial surveillance for arch obstruction, integrated with changes in right ventricular function and tricuspid valve regurgitation, is recommended after the Norwood procedure to improve outcomes. 相似文献110.